Many years ago the Apotex Group of Companies accepted the challenge to
build a world class Canadian-owned pharmaceutical company with a commitment to excellence.
This includes our Research, Development, Production and Distribution that all fits
together for the most important objective, "Service to our Customers".
We have done this by investing in our future by building the best
facilities, committing over $2 billion for R&D over the next 10 years, improving our
internal systems with SAP, and by supporting and strengthening our human resources.
Customer satisfaction begins with employee satisfaction.
A commitment to 100% on-time delivery - followed up with continuous
measurement of progress against this goal - forms the foundation of the Apotex Group of Companies' approach to
supply chain management. We know that on-time delivery is absolutely the only road to a satisfied customer at the
end of each transaction.
As consolidation in the pharmaceutical industry continues and the Canadian-owned
companies disappear, it is important to understand what the Apotex Group is trying to do in the building of a Canadian
integrated pharmaceutical company. Our commitment is to a complete product line, including generic, innovative and biotech
medicines to meet world healthcare needs.
The reasons for doing all of this are simple - we are not just any
pharmaceutical company, we are Canada's pharmaceutical company that
advances the use of generics worldwide.
Jack Kay
President & COO
